181 related articles for article (PubMed ID: 231062)
1. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
2. Plasma glucagon in insulinoma.
Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
[TBL] [Abstract][Full Text] [Related]
3. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
Kahn CR; Bhathena SJ; Recant L; Rivier J
J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
[No Abstract] [Full Text] [Related]
4. Plasma insulin response to various secretagogues in insulinoma.
Ohneda A; Kobayashi T; Nihei J
Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
[TBL] [Abstract][Full Text] [Related]
5. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
Nelson RL; Service FJ; Go VL
Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
[TBL] [Abstract][Full Text] [Related]
7. Plasma insulin studies in the diagnosis of insulinoma.
McKiddie MT; Buchanan KD; Abernethy RJ
Scott Med J; 1969 Jun; 14(6):200-8. PubMed ID: 4307323
[No Abstract] [Full Text] [Related]
8. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
9. [Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors].
Drost H; Berger M; Berchtold P; Wiegelmann W; Zimmermann H; Gries FA
Med Welt; 1976 Jul; 27(28):1381-3. PubMed ID: 183080
[No Abstract] [Full Text] [Related]
10. Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.
Lins PE; Efendić S
Diabetes; 1979 Mar; 28(3):190-5. PubMed ID: 221293
[No Abstract] [Full Text] [Related]
11. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Hendriks T; Jansen JB; van Tongeren JH
Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
[TBL] [Abstract][Full Text] [Related]
12. Malignant somatostatinoma: clinical features and metabolic studies.
Axelrod L; Bush MA; Hirsch HJ; Loo SW
J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
[No Abstract] [Full Text] [Related]
13. [Pancreatic function tests].
Abe M; Ikeda Y; Yaginuma M; Shimizu N
Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
[No Abstract] [Full Text] [Related]
14. Letter: Somatostatin and insulinoma.
Christensen SE; Hansen AP; Lundbaek K; Orskov H; Seyer-Hansen K
Lancet; 1975 Jun; 1(7922):1426. PubMed ID: 49589
[No Abstract] [Full Text] [Related]
15. Diagnostic value of intravenous glucagon test in insulinoma.
Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
[TBL] [Abstract][Full Text] [Related]
16. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
[No Abstract] [Full Text] [Related]
17. [A case of insulinoma].
Deliège M; Jardon-Jeghers C
Acta Clin Belg; 1980; 35(5):306-13. PubMed ID: 6261504
[No Abstract] [Full Text] [Related]
18. Hypoglycemia: tolbutamide and leucine tests in insulinoma.
Frawley TF; Pensuwan S
Med Clin North Am; 1968 Mar; 52(2):283-94. PubMed ID: 4297807
[No Abstract] [Full Text] [Related]
19. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
Luyckx AS; Lefebvre PJ
Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
